A final day on neurotechnology, AI drug discovery that must prove its value and a live brain-computer interface demonstration ...

BioMarin signs deal worth $475 M with Korea's GC Biopharma and Hanmi Pharm for potential treatment of Fabry Disease ...

Waters Corporation has announced AI-Powered Peak Integration, the next step in its strategy to build intelligent AI, machine ...

Fund has announced a total investment of approximately JPY 1.06 billion ($6.8 million) in nine R&D projects for the ...

Speaking to BioSpectrum Asia at BIOPLUS-INTERPHEX KOREA 2026, Dr Sally Temple highlights how advances in RPE transplantation, ...

M42 and the American University in Dubai (AUD) have signed a Memorandum of Understanding (MoU) to expand practical learning ...

Under the agreement, Astellas receives an exclusive option which, on exercise, will grant Astellas a worldwide license to ...

PeptiDream Inc., a public biopharmaceutical company based in Kawasaki, Japan, focused on the discovery and development of ...

If Day 1 of BIX 2026 asked what makes a Korean asset partnerable, Day 2 asked what happens once someone wants it. Thursday's ...

SG Austria/Austrianova announces a peer-reviewed perspective exploring encapsulated cells for sustained delivery of the ageing-associated protein Klotho.

Singapore’s HSA approves MSD’s CAPVAXIVE for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults ...

DKSH to establish healthcare platform in Middle East and scale up capabilities with acquisition of NewBridge Pharma ...